The safety and efficacy of oral Arborium plus, a herbal liquid formulation in the treatment of diabetic foot syndrome: an open label study
Keywords:Oral Arborium plus, Diabetic foot ulcer, Type-2 diabetes, Herbal formulation
Background: Diabetic foot ulcers are the most universal cause of non-traumatic amputations of the foot in developing countries. One of the treatment modalities is to improve the peripheral blood supply to the area of ulcer. To this purpose the study was done to evaluate the safety and efficacy of oral Arborium plus (herbal liquid formulation) in the wound closure of diabetic foot patients.
Methods: 50 patients were randomly assigned to either of the groups (each group 25 patients) to receive either the test drug (Arborium plus) at tertiary care teaching hospital, it was an open label prospective and interventional parallel group study to evaluate the efficacy and safety of Arborium plus in diabetic foot syndrome. The study participants were randomized into control and intervention groups. Base line measurements of vascular flow was ankle- brachial pressure index (ABPI) and wound size measurement.
Results: The baseline characteristics of the patients age in years test and control group 68±12.3 and 67±13.4 respectively. Male/female in both groups was 21/4 and 22/3 respectively. Duration of diabetes in years 8.65±8.3 and 8.5±7.6 respectively. BMI was 25.11±4.15 and 24.75±0.85, duration of smoking (years) 17.3±9.5 and 19.5±10.5 respectively in both groups. Among the test group who received the proprietary formulation of Arborium plus, there was a significant reduction in the wound size.
Conclusions: Wound healing and ABPI improvements were observed with usage of Arborium plus suggest an improvement in peripheral vascular flow in diabetic foot subjects.
Volmer M. Thole and Ralf Lobmann. Neuropathy and Diabetic Foot Syndrome. Int J Mol Sci. 2016;17:917.
Risse A. The diabetic foot syndrome—An interdisciplinary challenge. Hamostaseologie. 2007;27:117-22.
Van Battum P, Schaper N, Prompers L, Apelqvist J, Jude E. Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation. Diabet Med J Br Diabet Assoc. 2011;28:199-205.
Zimmermann A, Reeps C, Hartl F, Ockert S, Eckstein HH. The diabetic foot. Der Chir Z Fuer Alle Geb Der Oper Med. 2009;80:430-6.
Monteiro-Soares M, Boyko EJ, Ribeiro J, Dinis-Ribeiro LM. Risk stratiﬁcation systems for diabetic foot ulcers: A systematic review. Diabetologia. 2011;54:1190-9.
Boulton AJ. The diabetic foot: Grand overview, epidemiology and pathogenesis. Diabet Metab Res Rev. 2008;24:S3-S6.
Boulton AJ. Diabetic neuropathy and foot complications. Handbook Clin Neurol. 2014;126:97-107.
Boulton AJ. The pathway to foot ulceration in diabetes. Med Clin N Am. 2013;97:775-90.
Lobmann R. Diabetic foot syndrome. Der Internist. 2011;52:539-48.
Ziegler D, Keller J, Maier C, Pannek J. Diabetic neuropathy. Exp Clin Endocrinol Diabet Off J Ger Soc Endocrinol Ger Diabet Assoc. 2014;122:406-15.
Srivastava P. Rhododendron arboretum: An overview. J Applied Pharma Sci. 2012;2(1):158-62.
Bhandary MR, Kuwabata J. Antidiabetic activity of Laligurans (Rhododendronarboreum Sm.) flower. J Food Sci Tech Nepal. 2008;4:61-3.
Verma N, Singh AP, Amresh G, Sahu PK, Rao CV. Antiinflammatory and nociceptive activity of Rhododendron arboreum. J Pharm Res. 2010;3:1376-80.
Verma N, Singh AP, Amresh G, Sahu PK, Rao CV. Protective effect of ethyl acetate fraction of Rhododendron arboreum flowers against carbon tetrachloride-induced hepatotoxicity in experimental models. Indian J Pharmacol. 2011;43(3):291-5.
Verma N, Singh AP, Amresh G, Sahu PK, Rao CV. Antidiarrheal potential of standardized extract of Rhododendron arboreum Smith flowers in experimental animals. Indian J Pharmacol. 2011;43(6):689-93.
Swaroop A, Prakash GA, Kumar SA. Simultaneous determination of quercetin, rutin and coumaric acid in flowers of Rhododendron arboreum by HPTLC. Chromatographia. 2005;62(12):649-52.
Armstrong DG, Nguyen HC, Lavery LA, van Schie CH, Boulton AJ, Harkless LB. Off-Loading the Diabetic Foot Wound. Diabetes Care. 2001;24(6):1019-22.
Young MJ, Breddy JL, Veves A, Boulton AJ: The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds: a prospective study. Diabetes Care. 1994;17:557-60.
Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG. Choosing apractical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med. 1998;158:289-92.
Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system: the contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care. 1998;21:855-9.
ShabaniVaraki E, Gargiulo GD, Penkala S, Breen PP. Peripheral vascular disease assessment in the lower limb: a review of current and emerging non-invasive diagnostic methods. Biomed Eng Online. 2018;17(1):61.
Milleville RD. The Rhododendron of Nepal. Himal Books, Lalitpur, Nepal P. 2002: 136.
Murty D, Rajesh E, Raghava D, Raghavan TV, Surulivel MK. Hypolipidemic effect of arborium plus in experimentally induced hypercholestermic rabbits. Yakugaku Zasshi. 2010;130(6):841-6.
Thangaraj V. Hypolipidemic effect of Rhododendron arboretum Sm. linn flower juice in experimentally induced hypercholestermic rabbits. Int J Pharm Biomed Res. 2013;4(1):46-9.
Sonar PK, Singh R, Khan S, Sarafa S. Isolation, characterization and activity of the flowers of rhododendron arboreum (ericaceae). e-J Chem. 2012;9(2):631-6.